Please check your internet connection and try again.
# Walethmade bromide
## Overview
There is no pharmacological agent known as "Walethmade bromide." It is highly likely this is a typographical error or a misspelling of **Aclidinium bromide** (an anticholinergic bronchodilator) or a similarly named quaternary ammonium compound. **Caution:** Do not administer or prescribe under this name. Please verify the intended medication with the originating prescriber or pharmacy records.
## Primary Indications
If referencing a generic long-acting muscarinic antagonist (LAMA) like Aclidinium: Maintenance treatment of chronic obstructive pulmonary disease (COPD).
## Adult Dosing
Assuming Aclidinium bromide: 400 mcg (one inhalation) twice daily.
## Pediatric Dosing
Not indicated for pediatric use.
## Dose Adjustments
No dose adjustment required for renal or hepatic impairment.
## Contraindications
Hypersensitivity to aclidinium bromide, atropine, or milk proteins (due to lactose monohydrate content).
## Adverse Effects
* Common: Headache, nasopharyngitis, cough.
* Serious: Paradoxical bronchospasm, anticholinergic effects (urinary retention, narrow-angle glaucoma exacerbation).
## Key Drug Interactions
Avoid concomitant use with other anticholinergic agents (e.g., tiotropium, ipratropium) as it may increase the risk of systemic anticholinergic adverse effects.
## Monitoring
* Monitor for paradoxical bronchospasm after the first dose.
* Assess for worsening urinary symptoms or changes in vision.
## Clinical Pearls
If this inquiry refers to a different specific "bromide" salt, ensure the suffix does not imply a misidentified sedative or neuromuscular blocker. Always verify the medication name using the manufacturer’s package insert or a verified clinical database (e.g., Lexicomp, Micromedex).
***
**Disclaimer:** This information is for educational purposes only. As "Walethmade bromide" is not a recognized pharmaceutical entity, do not attempt to dose or administer based on this information. Always verify the drug name, indication, and dose with the patient's official medical record, a board-certified clinical pharmacist, or current prescribing information before administration.